204(top 100%)
PR articles
34.2K(top 1%)
PR citations
76(top 100%)
PR h-index
82(top 100%)
h-index
219
documents
40.6K
doc citations
3.5K
citing journals
100
times ranked

Publications

204 PR articles • 35,589 PR citations • Sorted by year • Download PDF (PDF by citations)
#ArticleIFPR CitationsLinks
1Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response
Science Advances, 2024, 10,
11.214Citations (PDF)
2Description of a novel subtype of acute myeloid leukemia defined by recurrent <i>CBFB</i> insertions
Blood, 2023, 141, 800-805
4.26Citations (PDF)
3A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer
Nature Cancer, 2023, 4, 1326-1344
22.9102Citations (PDF)
4Clinical utility of whole-genome sequencing in precision oncology14.158Citations (PDF)
5Analytical demands to use whole-genome sequencing in precision oncology14.146Citations (PDF)
6Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology14.122Citations (PDF)
7Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
Gastroenterology, 2022, 162, 320-324.e4
1.042Citations (PDF)
8qmotif: determination of telomere content from whole-genome sequence data2.413Citations (PDF)
9Enhancer retargeting of <i>CDX2</i> and <i>UBTF::ATXN7L3</i> define a subtype of high-risk B-progenitor acute lymphoblastic leukemia
Blood, 2022, 139, 3519-3531
4.248Citations (PDF)
10Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
Genome Medicine, 2022, 14,
9.841Citations (PDF)
11Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment13.947Citations (PDF)
12Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care2.152Citations (PDF)
13DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association4.541Citations (PDF)
14Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma
JCO Precision Oncology, 2021, , 1160-1165
2.116Citations (PDF)
15Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status
Science Advances, 2021, 7,
11.242Citations (PDF)
16PRMT5: An Emerging Target for Pancreatic Adenocarcinoma
Cancers, 2021, 13, 5136
4.026Citations (PDF)
17The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
Cancers, 2021, 13, 4979
4.014Citations (PDF)
18ROR1 and ROR2 expression in pancreatic cancer
BMC Cancer, 2021, 21,
3.110Citations (PDF)
19Sex differences in oncogenic mutational processes13.986Citations (PDF)
20RAF1 rearrangements are common in pancreatic acinar cell carcinomas
Modern Pathology, 2020, 33, 1811-1821
4.933Citations (PDF)
21HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
Cell Reports, 2020, 31, 107625
6.4116Citations (PDF)
22Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia13.9171Citations (PDF)
23Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
Neuro-Oncology, 2018, 20, 873-884
0.9180Citations (PDF)
24Telomere sequence content can be used to determine ALT activity in tumours
Nucleic Acids Research, 2018, 46, 4903-4918
15.848Citations (PDF)
25Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
Clinical Cancer Research, 2018, 24, 569-580
6.8100Citations (PDF)
26Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
Gut, 2018, 67, 2142-2155
22.0112Citations (PDF)
27Exome-Wide Association Study of Pancreatic Cancer Risk
Gastroenterology, 2018, 154, 719-722.e3
1.046Citations (PDF)
28Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer4.254Citations (PDF)
29Whole-genome landscape of pancreatic neuroendocrine tumours
Nature, 2017, 543, 65-71
39.5913Citations (PDF)
30Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
Nature Genetics, 2017, 49, 825-833
25.967Citations (PDF)
31Whole-genome landscapes of major melanoma subtypes
Nature, 2017, 545, 175-180
39.51,320Citations (PDF)
32Mitochondrial mutations and metabolic adaptation in pancreatic cancer4.961Citations (PDF)
33Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Cancer Cell, 2017, 32, 185-203.e13
38.51,824Citations (PDF)
34<i>EIF1AX</i> and <i>NRAS</i> Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas
Cancer Research, 2017, 77, 4268-4278
0.673Citations (PDF)
35Lost in translation: returning germline genetic results in genome-scale cancer research
Genome Medicine, 2017, 9,
9.827Citations (PDF)
36Hypermutation In Pancreatic Cancer
Gastroenterology, 2017, 152, 68-74.e2
1.0199Citations (PDF)
37Whole exome sequencing in patients with white matter abnormalities
Annals of Neurology, 2016, 79, 1031-1037
6.3135Citations (PDF)
38Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells
Nature, 2016, 534, 341-346
39.5226Citations (PDF)
39Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma
Carcinogenesis, 2016, 37, 356-365
2.954Citations (PDF)
40Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation
Cell Reports, 2016, 14, 907-919
6.4127Citations (PDF)
41Genomic analyses identify molecular subtypes of pancreatic cancer
Nature, 2016, 531, 47-52
39.53,324Citations (PDF)
42Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
Journal of Pathology, 2015, 237, 363-378
5.0113Citations (PDF)
43Whole–genome characterization of chemoresistant ovarian cancer
Nature, 2015, 521, 489-494
39.51,425Citations (PDF)
44A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing13.9288Citations (PDF)
45Whole genomes redefine the mutational landscape of pancreatic cancer
Nature, 2015, 518, 495-501
39.52,465Citations (PDF)
46PGTools: A Software Suite for Proteogenomic Data Analysis and Visualization
Journal of Proteome Research, 2015, 14, 2255-2266
3.654Citations (PDF)
47New <i>RAS</i>-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma
Journal of Clinical Oncology, 2015, 33, e52-e56
21.631Citations (PDF)
48Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial
Clinical Cancer Research, 2015, 21, 2029-2037
6.8225Citations (PDF)
49A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in non-typeable Haemophilus influenzae13.9128Citations (PDF)
50SOX9 regulates ERBB signalling in pancreatic cancer development
Gut, 2015, 64, 1790-1799
22.078Citations (PDF)
51Towards the Systematic Mapping and Engineering of the Protein Prenylation Machinery in Saccharomyces cerevisiae
PLoS ONE, 2015, 10, e0120716
2.427Citations (PDF)
52Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib
PLoS ONE, 2015, 10, e0125232
2.433Citations (PDF)
53Recommendations for Accurate Resolution of Gene and Isoform Allele-Specific Expression in RNA-Seq Data
PLoS ONE, 2015, 10, e0126911
2.444Citations (PDF)
54Abstract PR06: The ampullary adenocarcinoma, its molecular characterization and differentiation from the pancreatic ductal adenocarcinoma, duodenal adenocarcinoma, and cholangiocarcinoma
2015, ,
0Citations (PDF)
55SnapShot-Seq: A Method for Extracting Genome-Wide, In Vivo mRNA Dynamics from a Single Total RNA Sample
PLoS ONE, 2014, 9, e89673
2.459Citations (PDF)
56Rapid Identification of a Novel Complex I MT-ND3 m.10134C&gt;A Mutation in a Leigh Syndrome Patient
PLoS ONE, 2014, 9, e104879
2.49Citations (PDF)
57PRMT2 and RORγ Expression Are Associated With Breast Cancer Survival Outcomes
Molecular Endocrinology, 2014, 28, 1166-1185
2.652Citations (PDF)
58Clinical and pathologic features of familial pancreatic cancer
Cancer, 2014, 120, 3669-3675
4.156Citations (PDF)
59Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors13.9108Citations (PDF)
60Small RNA changes en route to distinct cellular states of induced pluripotency13.956Citations (PDF)
61Divergent reprogramming routes lead to alternative stem-cell states
Nature, 2014, 516, 192-197
39.5134Citations (PDF)
62Genome-wide characterization of the routes to pluripotency
Nature, 2014, 516, 198-206
39.5199Citations (PDF)
63Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling
International Journal of Cancer, 2014, 135, 1110-1118
4.5219Citations (PDF)
64An epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator13.9119Citations (PDF)
65Proteome adaptation in cell reprogramming proceeds via distinct transcriptional networks13.946Citations (PDF)
66Targeting mTOR dependency in pancreatic cancer
Gut, 2014, 63, 1481-1489
22.0114Citations (PDF)
67Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma
Clinical Cancer Research, 2014, 20, 3187-3197
6.836Citations (PDF)
68Minor class splicing shapes the zebrafish transcriptome during development7.869Citations (PDF)
69Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs
Genome Biology, 2014, 15,
8.2119Citations (PDF)
70Transcriptional switching in macrophages associated with the peritoneal foreign body response
Immunology and Cell Biology, 2014, 92, 518-526
2.742Citations (PDF)
71Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Cell, 2014, 157, 382-394
34.4445Citations (PDF)
72Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes
Blood, 2014, 123, 2682-2690
4.2118Citations (PDF)
73In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?3.220Citations (PDF)
74Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis13.9264Citations (PDF)
75Returning individual research results for genome sequences of pancreatic cancer
Genome Medicine, 2014, 6,
9.826Citations (PDF)
76Pancreatic cancer genomics3.355Citations (PDF)
77Identification of a Novel de Novo p.Phe932Ile KCNT1 Mutation in a Patient With Leukoencephalopathy and Severe Epilepsy
Pediatric Neurology, 2014, 50, 112-114
1.865Citations (PDF)
78Abstract 1715: Elucidating mechanisms of resistance to FGFR inhibitors in endometrial cancer
2014, ,
0Citations (PDF)
79Understanding pancreatic cancer genomes2.732Citations (PDF)
80Signatures of mutational processes in human cancer
Nature, 2013, 500, 415-421
39.59,190Citations (PDF)
81Mutations in DARS Cause Hypomyelination with Brain Stem and Spinal Cord Involvement and Leg Spasticity6.6174Citations (PDF)
82A De Novo Mutation in the β-Tubulin Gene TUBB4A Results in the Leukoencephalopathy Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum6.6196Citations (PDF)
83Clinical and molecular characterization of HER2amplified-pancreatic cancer
Genome Medicine, 2013, 5,
9.8107Citations (PDF)
84Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial α5 Integrin
Cancer Research, 2013, 73, 4579-4590
0.6105Citations (PDF)
85Integration-Free Induced Pluripotent Stem Cells Model Genetic and Neural Developmental Features of Down Syndrome Etiology
Stem Cells, 2013, 31, 467-478
3.3161Citations (PDF)
86Identification of Unsafe Human Induced Pluripotent Stem Cell Lines Using a Robust Surrogate Assay for Pluripotency
Stem Cells, 2013, 31, 1498-1510
3.322Citations (PDF)
87miR-139-5p is a regulator of metastatic pathways in breast cancer
Rna, 2013, 19, 1767-1780
3.8150Citations (PDF)
88MicroRNA-182-5p targets a network of genes involved in DNA repair
Rna, 2013, 19, 230-242
3.8115Citations (PDF)
89Characterization of an <i>ntrX</i> Mutant of Neisseria gonorrhoeae Reveals a Response Regulator That Controls Expression of Respiratory Enzymes in Oxidase-Positive Proteobacteria
Journal of Bacteriology, 2013, 195, 2632-2641
2.939Citations (PDF)
90MicroRNAs-140-5p/140-3p Modulate Leydig Cell Numbers in the Developing Mouse Testis
Biology of Reproduction, 2013, 88, 143-143
2.671Citations (PDF)
91Proteogenomic Analysis of Bradyrhizobium japonicum USDA110 Using Genosuite, an Automated Multi-algorithmic Pipeline3.239Citations (PDF)
92Somatic Point Mutation Calling in Low Cellularity Tumors
PLoS ONE, 2013, 8, e74380
2.470Citations (PDF)
93Whole Genome Sequence Analysis of the First Australian OXA-48-Producing Outbreak-Associated Klebsiella pneumoniae Isolates: The Resistome and In Vivo Evolution
PLoS ONE, 2013, 8, e59920
2.471Citations (PDF)
94Stromal Protein Ecm1 Regulates Ureteric Bud Patterning and Branching
PLoS ONE, 2013, 8, e84155
2.435Citations (PDF)
95Abstract A75: The IMPaCT trial: Individualised Molecular Pancreatic Cancer Therapy. A pilot, randomized, open label Phase II trial assessing first line treatment with gemcitabine or personalized treatment based on tumour molecular signature in patients with metastatic pancreatic cancer.
2013, ,
0Citations (PDF)
96PINA v2.0: mining interactome modules
Nucleic Acids Research, 2012, 40, D862-D865
15.8347Citations (PDF)
97Identification of molecular compartments and genetic circuitry in the developing mammalian kidney
Development (Cambridge), 2012, 139, 1863-1873
3.056Citations (PDF)
98<i>Sleeping Beauty</i> mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma7.8212Citations (PDF)
99RON is not a prognostic marker for resectable pancreatic cancer
BMC Cancer, 2012, 12,
3.118Citations (PDF)
100Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Nature, 2012, 491, 399-405
39.51,915Citations (PDF)
101Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages7.8368Citations (PDF)
102Integrated genome analysis suggests that most conserved non-coding sequences are regulatory factor binding sites
Nucleic Acids Research, 2012, 40, 7858-7869
15.839Citations (PDF)
103Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities
Stem Cell Research, 2012, 8, 58-73
0.6111Citations (PDF)
104Corrigendum to “Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities” [Stem Cell. 8 (2012) 58–73]
Stem Cell Research, 2012, 9, 58
0.61Citations (PDF)
105Identification of Novel Markers of Mouse Fetal Ovary Development
PLoS ONE, 2012, 7, e41683
2.445Citations (PDF)
106qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
PLoS ONE, 2012, 7, e45835
2.4100Citations (PDF)
107Abstract 5071: The genomic landscape of pancreatic cancer: from discovery to patient care
Cancer Research, 2012, 72, 5071-5071
0.60Citations (PDF)
108Sequencing transcriptomes in toto1.316Citations (PDF)
109MicroRNAs and their isomiRs function cooperatively to target common biological pathways
Genome Biology, 2011, 12,
8.2320Citations (PDF)
110Identification of Anchor Genes during Kidney Development Defines Ontological Relationships, Molecular Subcompartments and Regulatory Pathways
PLoS ONE, 2011, 6, e17286
2.480Citations (PDF)
111A High-Throughput Platform for Lentiviral Overexpression Screening of the Human ORFeome
PLoS ONE, 2011, 6, e20057
2.446Citations (PDF)
112Phasevarion Mediated Epigenetic Gene Regulation in Helicobacter pylori
PLoS ONE, 2011, 6, e27569
2.4120Citations (PDF)
113Refining transcriptional programs in kidney development by integration of deep RNA-sequencing and array-based spatial profiling
BMC Genomics, 2011, 12,
3.327Citations (PDF)
114Deep-transcriptome and ribonome sequencing redefines the molecular networks of pluripotency and the extracellular space in human embryonic stem cells
Genome Research, 2011, 21, 2014-2025
4.623Citations (PDF)
115The uniqueome: a mappability resource for short-tag sequencing
Bioinformatics, 2011, 27, 272-274
4.766Citations (PDF)
116X-MATE: a flexible system for mapping short read data
Bioinformatics, 2011, 27, 580-581
4.711Citations (PDF)
117Manganese regulation of virulence factors and oxidative stress resistance in Neisseria gonorrhoeae
Journal of Proteomics, 2010, 73, 899-916
2.440Citations (PDF)
118Vitamin C Promotes Widespread Yet Specific DNA Demethylation of the Epigenome in Human Embryonic Stem Cells  
Stem Cells, 2010, 28, 1848-1855
3.3167Citations (PDF)
119Ascorbate Promotes Epigenetic Activation of CD30 in Human Embryonic Stem Cells    
Stem Cells, 2010, 28, 1782-1793
3.345Citations (PDF)
120International network of cancer genome projects
Nature, 2010, 464, 993-998
39.52,301Citations (PDF)
121Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells
PLoS ONE, 2010, 5, e13809
2.446Citations (PDF)
122Regulated post-transcriptional RNA cleavage diversifies the eukaryotic transcriptome
Genome Research, 2010, 20, 1639-1650
4.681Citations (PDF)
123Use of DNA–Damaging Agents and RNA Pooling to Assess Expression Profiles Associated with BRCA1 and BRCA2 Mutation Status in Familial Breast Cancer Patients
PLoS Genetics, 2010, 6, e1000850
3.39Citations (PDF)
124A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells
Genome Research, 2010, 20, 1052-1063
4.6208Citations (PDF)
125Redirection of renal mesenchyme to stromal and chondrocytic fates in the presence of TGF-β2
Differentiation, 2010, 79, 272-284
2.46Citations (PDF)
126An Atlas of Combinatorial Transcriptional Regulation in Mouse and Man
Cell, 2010, 140, 744-752
34.4707Citations (PDF)
127Comparative gene expression analysis of genital tubercle development reveals a putative appendicular Wnt7 network for the epidermal differentiation
Developmental Biology, 2010, 344, 1071-1087
1.929Citations (PDF)
128Subfractionation of Differentiating Human Embryonic Stem Cell Populations Allows the Isolation of a Mesodermal Population Enriched for Intermediate Mesoderm and Putative Renal Progenitors
Stem Cells and Development, 2010, 19, 1637-1648
2.050Citations (PDF)
129Transcriptome-Wide Prediction of miRNA Targets in Human and Mouse Using FASTH
PLoS ONE, 2009, 4, e5745
2.428Citations (PDF)
130Phasevarions Mediate Random Switching of Gene Expression in Pathogenic Neisseria
PLoS Pathogens, 2009, 5, e1000400
4.5183Citations (PDF)
131GUDMAP - An Online GenitoUrinary Resource0.10Citations (PDF)
132Genome-Wide Identification of Long Noncoding RNAs in CD8+ T Cells
Journal of Immunology, 2009, 182, 7738-7748
0.6225Citations (PDF)
133Probabilistic resolution of multi-mapping reads in massively parallel sequencing data using MuMRescueLite
Bioinformatics, 2009, 25, 2613-2614
4.743Citations (PDF)
134NRED: a database of long noncoding RNA expression
Nucleic Acids Research, 2009, 37, D122-D126
15.8261Citations (PDF)
135RNA-MATE: a recursive mapping strategy for high-throughput RNA-sequencing data
Bioinformatics, 2009, 25, 2615-2616
4.745Citations (PDF)
136Identification of Human Embryonic Stem Cell Surface Markers by Combined Membrane-Polysome Translation State Array Analysis and Immunotranscriptional Profiling
Stem Cells, 2009, 27, 2446-2456
3.374Citations (PDF)
137Tiny RNAs associated with transcription start sites in animals
Nature Genetics, 2009, 41, 572-578
25.9337Citations (PDF)
138The regulated retrotransposon transcriptome of mammalian cells
Nature Genetics, 2009, 41, 563-571
25.9783Citations (PDF)
139The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line
Nature Genetics, 2009, 41, 553-562
25.9419Citations (PDF)
140Analysis of early nephron patterning reveals a role for distal RV proliferation in fusion to the ureteric tip via a cap mesenchyme-derived connecting segment
Developmental Biology, 2009, 332, 273-286
1.9256Citations (PDF)
14107-P023 GUDMAP – An online genitourinary resource
Mechanisms of Development, 2009, 126, S143
2.60Citations (PDF)
142Subtypes of familial breast tumours revealed by expression and copy number profiling2.688Citations (PDF)
143Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE)
Nature Biotechnology, 2008, 26, 305-312
32.5112Citations (PDF)
144Stem cell transcriptome profiling via massive-scale mRNA sequencing
Nature Methods, 2008, 5, 613-619
26.1986Citations (PDF)
145Transcriptome content and dynamics at single-nucleotide resolution
Genome Biology, 2008, 9, 234
12.7114Citations (PDF)
146The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition
Genome Biology, 2008, 9, R127
12.7293Citations (PDF)
147Kidney transcriptome reveals altered steroid homeostasis in NaS1 sulfate transporter null mice2.421Citations (PDF)
148A rescue strategy for multimapping short sequence tags refines surveys of transcriptional activity by CAGE
Genomics, 2008, 91, 281-288
2.894Citations (PDF)
149Atlas of Gene Expression in the Developing Kidney at Microanatomic Resolution
Developmental Cell, 2008, 15, 781-791
7.8198Citations (PDF)
150Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation
Genome Research, 2008, 18, 1433-1445
4.6710Citations (PDF)
151GUDMAP0.4253Citations (PDF)
152BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression
PLoS Genetics, 2008, 4, e1000080
3.312Citations (PDF)
153Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r–EGFP transgene reporter
Developmental Biology, 2007, 308, 232-246
1.9203Citations (PDF)
154Transcriptional analysis of early lineage commitment in human embryonic stem cells2.486Citations (PDF)
155Characterization of the OxyR regulon of Neisseria gonorrhoeae
Molecular Microbiology, 2007, 63, 54-68
2.787Citations (PDF)
156Dynamic transcription programs during ES cell differentiation towards mesoderm in serum versus serum-freeBMP4 culture
BMC Genomics, 2007, 8, 365
3.365Citations (PDF)
157Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers2.620Citations (PDF)
158Title is missing!
Genome Biology, 2006, 7, R10
12.769Citations (PDF)
159Title is missing!
Genome Biology, 2006, 7, R5
12.749Citations (PDF)
160Development of the Minimum Information Specification forIn SituHybridization and Immunohistochemistry Experiments (MISFISHIE)1.819Citations (PDF)
161Transcriptional profile reveals altered hepatic lipid and cholesterol metabolism in hyposulfatemic NaS1 null mice
Physiological Genomics, 2006, 26, 116-124
2.526Citations (PDF)
162A global role for EKLF in definitive and primitive erythropoiesis
Blood, 2006, 107, 3359-3370
4.2193Citations (PDF)
163PerR controls Mn-dependent resistance to oxidative stress in Neisseria gonorrhoeae
Molecular Microbiology, 2006, 60, 401-416
2.772Citations (PDF)
164Genome-wide analysis of mammalian promoter architecture and evolution
Nature Genetics, 2006, 38, 626-635
25.91,284Citations (PDF)
165Differential gene expression in the developing mouse ureter
Gene Expression Patterns, 2006, 6, 519-538
0.910Citations (PDF)
166Spatial gene expression in the T-stage mouse metanephros
Gene Expression Patterns, 2006, 6, 807-825
0.937Citations (PDF)
167Title is missing!
BMC Bioinformatics, 2006, 7, 82
3.022Citations (PDF)
168Definition and spatial annotation of the dynamic secretome during early kidney development
Developmental Dynamics, 2006, 235, 1709-1719
1.810Citations (PDF)
169Characterization of the breast cancer associatedATM7271T>G (V2424G) mutation by gene expression profiling
Genes Chromosomes and Cancer, 2006, 45, 1169-1181
3.220Citations (PDF)
170The Abundance of Short Proteins in the Mammalian Proteome
PLoS Genetics, 2006, 2, e52
3.3204Citations (PDF)
171Identification of three gene candidates for multicellular resistance in colon carcinoma
Cytotechnology, 2005, 46, 9-18
1.416Citations (PDF)
172The phasevarion: A genetic system controlling coordinated, random switching of expression of multiple genes7.8198Citations (PDF)
173Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome
Genome Research, 2005, 16, 11-19
4.6482Citations (PDF)
174Pax9 and Jagged1 act downstream of Gli3 in vertebrate limb development
Mechanisms of Development, 2005, 122, 1218-1233
2.694Citations (PDF)
175Identifying the Molecular Phenotype of Renal Progenitor Cells0.4127Citations (PDF)
176Effects of A1 adenosine receptor overexpression on normoxic and post-ischemic gene expression
Cardiovascular Research, 2003, 57, 715-726
5.512Citations (PDF)
177Mouse Proteome Analysis
Genome Research, 2003, 13, 1335-1344
4.6101Citations (PDF)
178Systematic Characterization of the Zinc-Finger-Containing Proteins in the Mouse Transcriptome
Genome Research, 2003, 13, 1430-1442
4.695Citations (PDF)
179Analysis of the Mouse Transcriptome for Genes Involved in the Function of the Nervous System
Genome Research, 2003, 13, 1395-1401
4.633Citations (PDF)
180Phosphoregulators: Protein Kinases and Protein Phosphatases of Mouse
Genome Research, 2003, 13, 1443-1454
4.645Citations (PDF)
181Characterizing Embryonic Gene Expression Patterns in the Mouse Using Nonredundant Sequence-Based Selection
Genome Research, 2003, 13, 2609-2620
4.628Citations (PDF)
182The Mouse Secretome: Functional Classification of the Proteins Secreted Into the Extracellular Environment
Genome Research, 2003, 13, 1350-1359
4.675Citations (PDF)
183Exploration of the Cell-Cycle Genes Found Within the RIKEN FANTOM2 Data Set
Genome Research, 2003, 13, 1366-1375
4.616Citations (PDF)
184Generation of Diversity in the Innate Immune System: Macrophage Heterogeneity Arises from Gene-Autonomous Transcriptional Probability of Individual Inducible Genes
Journal of Immunology, 2002, 168, 44-50
0.694Citations (PDF)
185Tissue-specific gene expression in soybean (Glycine max) detected by cDNA microarray analysis
Journal of Plant Physiology, 2002, 159, 1361-1374
4.140Citations (PDF)
186Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells
Oncogene, 2002, 21, 8196-8205
6.7109Citations (PDF)
187Expression of a novel mammalian epidermal growth factor-related gene during mouse neural development
Mechanisms of Development, 2001, 102, 209-211
2.647Citations (PDF)
188Transcriptional responses to ischemia in A1AR transgenic and wild-type hearts3.80Citations (PDF)
189Characterization of RasGRP2, a Plasma Membrane-targeted, Dual Specificity Ras/Rap Exchange Factor
Journal of Biological Chemistry, 2000, 275, 32260-32267
2.3114Citations (PDF)
190Sexually dimorphic expression of protease nexin-1 and vanin-1 in the developing mouse gonad prior to overt differentiation suggests a role in mammalian sexual development
Human Molecular Genetics, 2000, 9, 1553-1560
3.096Citations (PDF)
191Cloning, Mapping, and Expression Analysis of a Gene Encoding a Novel Mammalian EGF-Related Protein (SCUBE1)
Genomics, 2000, 70, 74-81
2.881Citations (PDF)
192A 500-kb Sequence-Ready Cosmid Contig and Transcript Map of theMEN1Region on 11q13
Genomics, 1999, 55, 49-56
2.83Citations (PDF)
193Characterization of the mouse Men1 gene and its expression during development
Oncogene, 1998, 17, 2485-2493
6.7137Citations (PDF)
194Characterisation of a New Human and Murine Member of the DnaJ Family of Proteins2.14Citations (PDF)
195The Mouse Y Chromosome Interval Necessary for Spermatogonial Proliferation is Gene Dense with Syntenic Homology to the Human AZFa Region
Human Molecular Genetics, 1998, 7, 1713-1724
3.098Citations (PDF)
196Analysis of the Promoter Region of the Human VEGF-Related Factor Gene2.143Citations (PDF)
197Construction of a 1.2-Mb Sequence-Ready Contig of Chromosome 11q13 Encompassing the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene
Genomics, 1997, 44, 94-100
2.834Citations (PDF)
198Expression of the VEGF-Related Factor Gene in Pre- and Postnatal Mouse2.124Citations (PDF)
199Characterization of the Murine VEGF-Related Factor Gene2.119Citations (PDF)
200Confirmation of a susceptibility locus on chromosome 13 in Australian breast cancer families
Human Genetics, 1996, 98, 80-85
3.111Citations (PDF)
201Exclusion of the phosphoinositide-specific phospholipase C?3 ( PLCB3 ) gene as a candidate for multiple endocrine neoplasia type 1
Human Genetics, 1996, 99, 130-132
3.18Citations (PDF)
202Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase C β3 gene (PLCB3)
Genomics, 1995, 26, 467-472
2.820Citations (PDF)
203The phospholipase C β3 gene located in the MEN1 region shows loss of expression in endocrine tumours
Human Molecular Genetics, 1994, 3, 1775-1781
3.053Citations (PDF)
204Tumour-induced host stromal-cell transformation: Induction of mouse spindle-cell fibrosarcoma not mediated by gene transfer4.519Citations (PDF)